Clinical Trial Update: Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial from NYU Langone Health is evaluating biomarker-guided, personalized treatment for individuals with alcohol use disorder co-occurrin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Post-traumatic Stress Disorder

Snippet

Sponsor: NYU Langone Health | Conditions: Post Traumatic Stress Disorder, Alcohol Use Disorder | Phase 2 | Status: RECRUITING